INTRODUCTION
Ubiquitylation controls critical signaling pathways in eukaryotes and is essential for cell proliferation, differentiation, and survival (Deshaies and Joazeiro, 2009; Schulman and Harper, 2009) . The transfer of a single ubiquitin to a substrate, a reaction referred to as monoubiquitylation, typically alters interactions, localization, or activity of the modified protein (Dikic et al., 2009) . Conversely, the attachment of multiple ubiquitin molecules results in polymeric chains that, depending on their connectivity, could have unique functions.
Ubiquitin chain formation can occur through seven lysine residues or the amino terminus of ubiquitin, leading to the assembly of multiple chains with distinct topology (Komander and Rape, 2012) . All linkages have been detected in cells, and their abundance changes during cell division or differentiation (Peng et al., 2003; Xu et al., 2009 ). The first chain types to be discovered, termed canonical ubiquitin chains, had distinct consequences for the modified protein: whereas chains connected through K48 of ubiquitin promoted proteasomal degradation, K63-linked chains regulated the assembly of oligomeric complexes (Chau et al., 1989; Johnson et al., 1995; Spence et al., 2000; Wang et al., 2001) . Based on these observations, it was hypothesized that many ubiquitylation marks might trigger unique biological outcomes, reminiscent of a code.
Yet as roles of atypical conjugates are only beginning to emerge, the complexity of ubiquitin-dependent signaling remains poorly understood. In addition to the canonical conjugates, homogenous chains could also be formed by modification of M1, K6, K11, K27, K29, or K33 (Jin et al., 2008; Tokunaga et al., 2009 ). Several of these linkages can mediate proteasomal degradation, but the reason for this redundancy is unclear (Jin et al., 2008; Johnson et al., 1995; Koegl et al., 1999; Xu et al., 2009) . Conjugates of more complex topology, such as mixed chains, are formed during endocytosis or immune signaling (Boname et al., 2010; Emmerich et al., 2013) . Proteomic analyses also showed that a single ubiquitin molecule embedded within a chain can be modified at two or more sites, a process that leads to the assembly of branched conjugates (Kim et al., 2007; Peng et al., 2003) . In vitro, branched linkages through K27, K29, or K33 of ubiquitin impede proteasomal recognition (Kim et al., 2007) . However, as neither physiological enzymes nor substrates are known, it remains unclear whether branched conjugates play important roles in ubiquitin-dependent signaling.
The anaphase-promoting complex (APC/C) provides a powerful model to test for functions of atypical chains. Whereas yeast APC/C modifies its substrates with canonical K48-linked chains (Rodrigo-Brenni and Morgan, 2007) , the metazoan APC/C assembles atypical K11-linked conjugates to drive proteasomal degradation and mitotic exit (Jin et al., 2008; Matsumoto et al., 2010) . In human cells, the APC/C initiates chain formation by using the E2 Ube2C (also known as UbcH10, UbcX, Vihar, or E2C). Although Ube2C prefers to synthesize K11 linkages, it also connects ubiquitin molecules through K48 or K63 (Kirkpatrick et al., 2006; Williamson et al., 2011) . Another APC/C-E2, Ube2S, recognizes substrate-attached ubiquitin to produce specific K11-linked chains (Wickliffe et al., 2011; Williamson et al., 2009; Wu et al., 2010) . The abundance of K11 linkages rises dramatically during mitosis, when the APC/C is active, and this boost in K11-linked chain formation is dependent on Ube2S (Matsumoto et al., 2010; Wickliffe et al., 2011) . However, as substrates that require Ube2S for degradation have not been reported, the physiological importance of K11-linked chains has not been fully addressed.
In this study, we have identified APC/C substrates, including the kinase Nek2A, that require Ube2S for degradation. The reconstitution of Nek2A-ubiquitylation revealed that Ube2S does not simply extend a conjugate but instead branches multiple K11-linked chains off the assemblies produced by Ube2C. Compared to homogenous chains, branched conjugates synthesized by the APC/C increase the efficiency of proteasomal substrate recognition and, accordingly, are required for the degradation of cell-cycle regulators at times of limited APC/C activity. Our work identifies the APC/C as an enzyme that synthesizes branched ubiquitin chains and ascribes an important role to these conjugates in providing an improved signal for proteasomal degradation.
RESULTS

Prometaphase APC/C Substrates Require Ube2S for Degradation
The metazoan APC/C cooperates with Ube2S to assemble K11-linked chains that drive the degradation of cell-cycle regulators during mitosis and G1. However, as depletion of Ube2S showed few defects during mitosis, it is not fully understood whether K11-linked chains have essential roles for cell division (Garnett et al., 2009; Williamson et al., 2009; Wu et al., 2010) . To address this issue, we systematically screened cells that expressed Ube2S at less than 2% of their normal abundance for changes in protein levels. Strikingly, depletion of Ube2S caused a strong increase in the abundance of Nek2A kinase during prometaphase, a cell-cycle stage when the APC/C is partially inhibited by the spindle checkpoint ( Figure 1A ; Figure S1A available online). The accumulation of Nek2A was seen with multiple small interfering RNAs (siRNAs) against Ube2S and reversed by stable expression of siRNA-resistant Ube2S ( Figures 1A and S1B) . Depletion of Ube2S neither changed the levels of Nek2A mRNA nor the mitotic stage of synchronized cells, suggesting that it instead affected the stability of the Nek2A protein ( Figures  S1C and S1D ).
Based on these findings, we tested by cycloheximide chase experiments whether Ube2S was required for APC/C substrate degradation during prometaphase. Indeed, the depletion of Ube2S resulted in a pronounced increase in the half-life of Nek2A and of the CDK-inhibitor p21, another APC/C substrate ( Figure 1B) . Accordingly, purification of ubiquitin conjugates from prometaphase cells revealed that Ube2S was required for the attachment of high molecular weight (MW) chains to endogenous Nek2A and p21 ( Figures 1C and S1E ). Ube2S also mediated the ubiquitylation of Cdc20 ( Figures 1B and 1C) , a reaction that disassembles spindle checkpoint complexes (Foster and Morgan, 2012; Reddy et al., 2007; Uzunova et al., 2012; Williamson et al., 2009) . By contrast, another prometaphase substrate, cyclin A, was not stabilized ( Figure S1A ), which might be due to incomplete Ube2S depletion or redundant mechanisms governing degradation of this cell-cycle regulator (Kikuchi et al., 2013) . In agreement with our results, the loss of Ube2S had pronounced effects on early mitosis: it delayed sister chromatid separation, blocked release of cells from a spindle checkpoint-induced arrest, and sensitized cells to low concentrations of nocodazole ( Figures 1D, 1E , and S1F). These experiments, therefore, show that Ube2S is important during prometaphase, a cell-cycle time when the spindle checkpoint reduces overall APC/C activity.
The APC/C Synthesizes Branched Ubiquitin Chains In Vitro To dissect the role of Ube2S during prometaphase, we reconstituted the ubiquitylation of Nek2A. Previous work has shown that Ube2S elongates K11-linked chains that have been initiated by Ube2C or Ube2D (Garnett et al., 2009; Williamson et al., 2009; Wu et al., 2010) . In agreement with this model, the APC/C and its E2s modified Nek2A with high MW conjugates in the presence of wild-type, but not a K11R mutant of ubiquitin (ubi R11 ; Figures 2A and S2A) . Chains derived with ubi R11 , which cannot be used by Ube2S for chain formation, closely mirrored those seen in cells lacking Ube2S, showing that our reconstitution recapitulated the in vivo modification of Nek2A. Surprisingly, the MW of Nek2A conjugates was strongly reduced in reactions that contained a ubiquitin mutant with K11 as the only site for chain formation (ubi K11 ; Figures 2A and S2A ). This was in contrast to substrates modified by Ube2S alone ( Figure 2B ) and suggested that formation of high MW chains on Nek2A was dependent on multiple linkages.
Conjugates with multiple linkages could be mixed chains, in which distinct connections are used within a single conjugate, or branched structures, in which at least one moiety received two or more ubiquitin molecules. To distinguish between these possibilities, we incubated Nek2A with mixtures of ubi R11 and ubi
K11
. If the APC/C assembled mixed chains, it could sequentially use ubi R11 and ubi K11 to build conjugates of similar MW as seen with ubiquitin. In contrast, branched conjugates that result from concurrent modification of K11 and another ubiquitin lysine could not be assembled; thus, if the APC/C were a branching enzyme, chains formed with ubi K11 and ubi R11 should be of lower MW than those with WT-ubiquitin. Importantly, Nek2A was modified with low MW conjugates in the presence of ubi R11 and ubi
, suggesting that the APC/C decorated this substrate with branched chains (Figures 2A and S2A) .
As physiological enzymes for the assembly of branched chains are unknown, we wished to test the notion that the APC/C could produce such conjugates. To this end, we circumvented the initiation step and incubated APC/C and Ube2S with substrates already linked to linear chains of defined length. We investigated two prometaphase APC/C substrates: Nek2A, which requires Ube2S for degradation, and cyclin A, which can be robustly ubiquitylated in vitro (Rape et al., 2006) . We supplemented these reactions with methylubiquitin, which allows transfer of the first ubiquitin by Ube2S but interferes with further chain extension. If Ube2S elongates pre-existing chains, only the distal ubiquitin of our substrates should be modified, yet if it assembles branched conjugates, internal moieties could be ubiquitylated as well. Demonstrating the formation of branched chains, Ube2S added two methylubiquitin molecules to Ub-Ub-cyclin A, and it attached one ubiquitin to a substrate variant that lacked Lys11 in its distal moiety (Ub R11 -Ub-cyclin A; Figure 2C ).
Ube2S synthesized the branched linkage on Ub
R11
-Ub-cyclin A with the same specificity and efficiency as seen for elongation (Figures 2D and S2B) , and it branched ubiquitin molecules off substrates with longer chains, such as Ub 3 -cyclin A and Ub 3 -Nek2A ( Figures 2D and 2E ). If these assays were performed with WT-ubiquitin, Ube2S branched a block of 6 K11-linked molecules off each ubiquitin containing a free K11, thereby effectively modifying Ub-Ub-cyclin A with chains that had twice the MW as those on Ub-cyclin A or Ub R11 -Ub-cyclin A ( Figure 2C ).
Ube2S acts after Ube2C, which decorates APC/C substrates with short chains containing 50% K11 linkages, but also K48 and K63 linkages (Kirkpatrick et al., 2006) . If Ube2C produced the latter two linkages, Ube2S could use an internal ubiquitin to branch off a K11-linked chain. To test this hypothesis, we incubated Ub-cyclin A with Ube2C at concentrations that led to the formation of short chains (Ub 3 -cyclin A). We stopped the initiation step with an excess of Ube2C
C114S
, which does not affect Ube2S (Wickliffe et al., 2011) , and then added methylubiquitin and Ube2S. Again demonstrating the assembly of branched conjugates, Ube2S attached up to three ubiquitin molecules to Ub 3 -cyclin A produced by Ube2C ( Figure S2C ). In addition, we performed single-substrate turnover reactions with ubi R48/63 or ubi K6/K11 . These mutants support formation of K11-linked chains but prevent the synthesis of K48 and K63 linkages by Ube2C that are required for branching by Ube2S. Importantly, Ube2S decorated APC/C substrates with high MW chains in the presence of Ube2C and WT-ubiquitin, but not if Ube2C was omitted or ubi R48/63 or ubi K6/K11 was used ( Figures S2D and S2E ). Thus, the APC/C modifies substrates with branched chains in vitro.
The APC/C Synthesizes Branched Ubiquitin Chains in Cells As seen by mass spectrometry, the APC/C decorated Nek2A with chains containing K11, K48, and K63 linkages ( Figure S3A ). Based on the linkage specificities of Ube2C and Ube2S (Kirkpatrick et al., 2006; Williamson et al., 2009) , this finding implied that Ube2S assembles K11/K48 and K11/K63 branches, whichbecause of the multiple Lys and Arg residues separating the two attachment sites in the branched ubiquitin-cannot be detected by trypsin-based mass spectrometry. We, therefore, developed an alternative method to monitor formation of branched chains that allowed us to follow the synthesis of such conjugates in cells ( Figure 3A ): we identified two ubiquitin residues, Gly53 and Glu64, that permitted insertion of a TEVcleavage site and FLAG-epitope and were still recognized by Ube2S and APC/C (Figures 3B, 3C, and S3B). We modified substrates with ubi 53TEV and ubi 64TEV/FLAG and then treated the reaction products with TEV protease. This led to the collapse of long chains and the emergence of diagnostic FLAG-reactive peptides: although modification of a distal moiety produced a small FLAG-reactive cleavage product, branches could be seen as additional species of higher MW. We had to use both ubi 53TEV and ubi 64TEV/FLAG , as this mixture proved to be most efficient in competing with WT-ubiquitin in later in vivo experiments. . Reaction products were analyzed by aHA-western blot. Red dot, first added ubiquitin; blue dot, second added ubiquitin; green dot, third added ubiquitin. (E) Ube2S efficiently modifies Nek2A with branched chains in vitro. Ub 3 -Nek2A was incubated with APC/C, Ube2S, and methylubiquitin or ubi R11 and analyzed by aNek2A-western blot. Nek2A was used as control (left). See also Figure S2 .
Importantly, diagnostic branched peptides were observed on Nek2A and cyclin A, further demonstrating that APC/C, Ube2C, and Ube2S modify substrates with branched chains ( Figure 3D ). By contrast, no branches were detected if we incubated Ubcyclin A or Ub 3 -Nek2A with APC/C and Ube2S, leading to the attachment of unbranched K11-linked chains ( Figure 3D ). Moreover, branched conjugates were absent if Nek2A was incubated with ubi R11/48/63 , a mutant that inhibits the formation of linkages . APC/C was purified from G1 phase, when it was active, or S phase, when APC/C-activity was low. APC/C was also inhibited by Emi1. Reactions were treated with TEV and analyzed by aFLAG-western. (F) APC/C was purified from prometaphase HeLa cells transfected with control or Ube2S siRNA and analyzed for copurifying K11-linked chains using aK11-western. (G) APC/C synthesizes branched chains in vivo. APC/C was purified from asynchronous cells expressing Figure S3 .
used by Ube2C and Ube2S, if the APC/C was purified from S phase cells, when it is inactive, or if active APC/C was inhibited by Emi1 ( Figures 3E and S3F ).
To determine whether the APC/C synthesizes branched chains in cells, we built on the observation that mitotic APC/C copurifies with proteins modified with K11-linked chains. Formation of these conjugates was dependent on Ube2S ( Figure 3F ), and they were eliminated by treatment with the K11-specific DUB Cezanne ( Figure S3C ). The K11-linked chains could be washed off the APC/C with high-salt buffers ( Figure S3D ), indicating that they were attached to endogenous substrates that remained bound to the APC/C following their modification. Therefore, we expressed FLAG ubi 53TEV and ubi 64TEV/FLAG under conditions that did not change ubiquitin levels ( Figure S3E ), purified the APC/C with coprecipitating substrates, and treated the samples with TEV. These experiments showed that endogenous APC/C substrates were modified with branched chains, with the branching pattern reflecting that of our in vitro analyses (Figure 3G ). The formation of branched linkages was severely reduced upon expression of ubi R11/48/63 , a mutant that obliterated branching in vitro, or upon synchronization of cells in S phase, when APC/C is inactive ( Figures 3H and S3G ). To test whether the APC/C modifies a specific substrate with branched chains, we purified ubiquitylated Nek2A from cells expressing ubi TEV constructs. Treatment of Nek2A purifications with TEV revealed a high fraction of branched chains, similar to the modification of Nek2A with such conjugates in vitro ( Figure 3I ). These findings were supported by the observation that expression of ubi K6/11 , a mutant that allows formation of K11-linked chains but prevents branched conjugates, strongly impaired the modification of APC/C substrates in cells ( Figure S3H ). We conclude that the APC/C assembles branched chains in cells, with Nek2A being an efficient substrate for this modification.
Altering the Linkage Specificity of Metazoan APC/C To determine specific functions of branched chains, we required an experimental system that allowed us to compare the fate of a substrate decorated with different homogenous chains or branched conjugates that resulted from a combination of the previous chain types, respectively. Such experiments are difficult to perform with Ube2C, as this E2 produces chains of mixed topology and length. To overcome this limitation, we engineered a K48-specific APC/C-E2 that, together with the physiological E2s, enabled us to modify substrates with K11-linked, K48-linked, or K11/K48-branched chains.
To generate a K48-specific APC/C-E2, we focused on the C-terminal peptide (CTP) of Ube2S: whereas deletion of the CTP abrogated binding of Ube2S to the APC/C, its fusion was sufficient to deliver a heterologous protein to the APC/C ( Figures  S4A-S4E ). If we appended the CTP to the K48-specific E2 Ube2G2, the resulting Ube2G2 CTP bound the APC/C ( Figures   S4F and S4G ) and ubiquitylated substrates with similar efficiency as Ube2S (Figures 4A and S4H ). The activity of Ube2G2 CTP toward the APC/C was inhibited by mutation of its active site ( Figures S4I and S4J ), addition of pseudosubstrate or competitive APC/C-inhibitors ( Figure 4B ), or mutation of APC/C-degrons in substrates ( Figure 4C ). Importantly, assays with ubiquitin mutants or linkage-specific antibodies demonstrated that Ube2G2 CTP modified APC/C substrates with K48-linked chains ( Figures 4D-4F ).
To test whether we could use the engineered E2 to produce branched chains, we incubated Ub-cyclin A with APC/C, Ube2G2 CTP , and ubiquitin under conditions that led to attachment of two K48-linked ubiquitin molecules (Ub 3 -cyclin A). We then inactivated Ube2G2 CTP by an excess of ubi R48 before we added Ube2S. As expected for the assembly of branched chains, Ube2S decorated Ub 3 -cyclin A with conjugates of much higher MW than those formed on Ub-cyclin A, a substrate that can only be modified with a single K11-linked chain (Figure 4G) . Similar high MW conjugates were detected in singlesubstrate turnover assays that contained Ube2G2 CTP and
Ube2S at the same time but were absent if only one E2 was used or the active site of Ube2G2 CTP was mutated ( Figure 4H ).
High MW chains were also seen in extracts and cells, if both Ube2S and Ube2G2 CTP were present ( Figures S5A and S5B ).
Sequential purification of these conjugates or treatment with the K11-specific DUB Cezanne revealed that they contained K11 and K48 linkages ( Figures S5C and S5D ). Importantly, Ube2S and Ube2G2 CTP did not produce high MW chains if incubated with mixtures of ubi R11 and ubi R48 ( Figure 4I ). Under these conditions, mixed chains with K11 and K48 linkages can be synthesized, but-as no ubiquitin contains K11 and K48 at the same time-K11/K48-branched chains cannot be produced. Thus, these experiments show that Ube2S and Ube2G2 CTP efficiently produce K11/K48-branched chains on APC/C substrates.
Branched Chains Are Stronger Proteolytic Signals
To determine the functional consequences of branched chains, we depleted Ube2S from cells to prevent the formation of such conjugates under physiological conditions. However, as loss of Ube2S also interferes with chain elongation, we used the physiological and engineered APC/C-E2s as a complementary approach to modify substrates with distinct chain types in vitro or to increase branched chain formation in cells. The combination of both strategies should allow us to pinpoint important roles of branched ubiquitin chains in vitro and in cells. We first tested how modification with distinct chains affects substrate recognition by effectors, such as the proteasome or p97. Intriguingly, whereas substrates modified with either K11-or K48-linked chains were similarly recognized by receptors of the proteasome or p97 ( Figure 5A ; Figures S6A-S6C) , the same proteins decorated with K11/K48-branched chains associated with these effectors much more efficiently ( Figures 5B,  5C , and S6D). The preferential recognition of branched chains was best seen in reactions that compared homogenous and branched conjugates at the same time ( Figures 5B and S6D) , and it was not a mere function of the number of ubiquitin molecules, as the proteasomal receptor S5A recognized branched chains more efficiently than K48-linked chains of equal MW (Figure 5C ). Similar effects were seen for physiological APC/C-E2s, which targeted Nek2A more efficiently to S5A by modifying it with branched, rather than homogenous, chains ( Figure 5D ). As expected from these results, branched chains were more efficient than were linear K11-linked conjugates in driving the degradation of Nek2A by purified proteasomes ( Figure 5E ). In contrast, the DUBs Cezanne or Usp37 similarly processed homogenous We next compared the distinct chain types in extracts, a system that had allowed the discovery of K11-linked chains and Ube2S (Jin et al., 2008; Williamson et al., 2009) . Extracts that either contained K11-or K48-specific APC/C-E2 supported the degradation of anaphase substrates with comparable efficiency (Figures S6G and S6H) . However, neither E2 by itself was able to promote degradation of a substrate with low affinity for the APC/ C or trigger substrate turnover under conditions of low APC/C activity ( Figures 5F and S6I) . In contrast, combination of K11-and K48-specific APC/C-E2s rapidly induced degradation even under challenging conditions (Figures 5F and S6I). As this was not observed with mixtures of ubi R11 and ubi R48 , the improved proteolytic capacity of combined APC/C-E2s required the formation of branched chains.
To analyze signaling by branched chains in vivo, we compared stable cell lines that expressed Ube2S to produce K11-linked chains, Ube2G2
CTP and siRNAs against Ube2S to synthesize K48-linked chains, or both K11-and K48-specific APC/C-E2s to assemble K11/K48-branched chains. To exclude overexpression artifacts, we selected cells that expressed less Ube2G2 CTP than endogenous Ube2S, and we generated cell lines that contained an extra copy of Ube2S as controls. Confirming our in vitro analyses, either K11-or K48-specific E2 promoted substrate degradation during anaphase, a time of high APC/C activity ( Figures S7A-S7C ). Still, branched chains appeared to be stronger signals: in normal cells, ubiquitylated substrates remain temporarily bound to the APC/C. By contrast, in cells assembling K11/K48-branched chains, in addition to the physiologicalbranched conjugates, such proteins were only detected on the APC/C if the proteasome was inhibited, suggesting that an increased formation of branched chains facilitated substrate extraction from APC/C and degradation by the proteasome (Figure 6A) . Accordingly, the levels of a model substrate were reduced upon coexpression of endogenous Ube2S and Ube2G2 CTP ( Figure S7D ). For Nek2A, the same results were obtained with physiological E2s: under conditions that supported formation of branched chains, Nek2A was rapidly extracted from the APC/C in a proteasome-dependent manner ( Figures  6B and 6C) . By contrast, if Ube2S was depleted and formation of branched chains was inhibited, Nek2A remained bound to the APC/C (Figure 6B ), coinciding with its stabilization and hyperphosphorylation of an APC/C subunit ( Figures 1B and Figures 6B-6D ). homogenous K11-linked chains and added to increasing concentrations of 26S proteasomes. Five independent titrations were monitored by autoradiography and quantified using ImageJ (n = 5; data are average ± SD; **p < 0.002 in paired t test; ***p < 0.001). The asterisk marks background degradation by proteasomes that copurify with APC/C. (F) Branched chains promote degradation more efficiently. Prometaphase extracts with endogenous Ube2S were treated with Ube2G2 CTP in the presence of ubiquitin mutants. The stability of geminin was monitored by western blot. Geminin was stable in extracts containing mixtures of ubi R11 and ubi
R48
, a condition that allows Ube2S and Ube2G2 CTP to assemble mixed, but not branched, chains.
See also Figure S6 .
Consistent with these observations, constitutive formation of K11/K48-branched chains resulted in spindle checkpoint bypass and aneuploidy, known consequences of increased APC/C-activity ( Figures 6E and S7E ). These phenotypes were observed most strongly at equimolar levels of Ube2G2 CTP and Ube2S ( Figure S7F ) and hence at conditions of most efficient branching, but they were observed much less dramatically if either K11-or K48-specific E2 was absent ( Figure 6F ) or if an extra copy of Ube2S was expressed ( Figure S7G ). These findings corroborated our Ube2S depletion studies: as mentioned before, loss of Ube2S and concomitant inhibition of branched chain formation impeded Cdc20 ubiquitylation, the reaction that drives checkpoint disassembly ( Figure 1C) ; sensitized cells to nocodazole ( Figure S1F) ; and blocked the release of cells from a spindle checkpoint-dependent arrest ( Figure 1D ). These experiments, therefore, support the notion that the formation of branched chains increases the proteolytic capacity of the APC/C, allowing it to efficiently degrade its prometaphase substrates.
DISCUSSION
In this study, we identified the APC/C as an enzyme that synthesizes branched ubiquitin chains and discovered a critical role for such conjugates in driving efficient proteasomal degradation. and Ube2S, as well as taxol, and the mitotic index was determined by automated microscopy (n = 3; 1,000 cells/condition; data are average ± SD; paired t test p < 0.02). See also Figure S7 .
Branched conjugates are synthesized during mitosis when Ube2S adds multiple K11-linked chains to mixed assemblies produced by the initiating E2s of APC/C (Figure 7 ). Branched chains strongly improve proteasomal substrate recognition, and accordingly, they are required for degradation at times of limited APC/C activity. We have observed similar branching activities for K48-and K63-specific enzymes (data not shown), suggesting that branched chains might frequently be employed in ubiquitin-dependent signaling.
How Are Branched Ubiquitin Chains Synthesized?
The assembly of branched chains depends on the cooperation of ubiquitylation enzymes with different linkage specificities, a condition fulfilled by the E2s of metazoan APC/C. Ube2C initiates chain formation by modifying substrates with short conjugates containing 50% K11 linkages, but also K48 and K63 linkages (Kirkpatrick et al., 2006) . At least in vitro, the APC/C is also able to nucleate chains with E2s of the Ube2D family, which synthesize ubiquitin chains with little linkage preference (Kirkpatrick et al., 2006) . If the initiating E2s use K48 or K63 linkages, K11 of an internal ubiquitin remains unmodified and provides a site for Ube2S to branch off a K11-linked chain. Ube2S is also able to modify ubiquitin molecules embedded in linear or completely K48-linked chains. This indicates that the presence of a free K11, but not of an overall chain linkage or structure, determines formation of a branch point. Consistent with this notion, Ube2S synthesized a branch with the same efficiency and specificity as it promoted chain elongation at the distal ubiquitin. It is interesting to note that Ube2S synthesizes a branched linkage with such high efficiency. As documented with linkagespecific antibodies, the accumulation of K11-linked chains during mitosis depends entirely on Ube2S (Matsumoto et al., 2010; Wickliffe et al., 2011) , indicating that its linkage specificity is different from most, if not all, mitotic ubiquitylation enzymes. Combined with its efficiency in synthesizing branched linkages, this observation implies that Ube2S could also branch K11-linked chains off conjugates initiated by other enzymes that interact with the APC/C. If this were the case, our findings raise the interesting possibility that the K11-specificity of metazoan APC/C did not arise because of a particular function of this topology, but because it allowed the formation of branched chains on as many initial conjugates as possible.
What Is the Signaling Function of Branched Ubiquitin Chains?
To decipher the information encoded by branched chains, we generated a toolkit of E2s that allowed us to modify substrates with K11-linked, K48-linked, or K11/K48-branched chains. A key result of these studies, we could show for the same protein that K11-and K48-linked chains mediate substrate binding to the proteasome with similar efficiency, and accordingly, both chain topologies trigger degradation at times at which the APC/C is fully active. These findings confirm that K11-linked chains are powerful degradation signals (Jin et al., 2008; Matsumoto et al., 2010) . Moreover, they show that the K11 specificity of the APC/C is not essential for the turnover of anaphase substrates, whereas K48-linked chains are not a prerequisite for substrate targeting to the proteasome. Our observations thus support studies that found most linkages to accumulate in response to proteasome inhibition, indicative of a proteolytic role for the majority of chain topologies (Dammer et al., 2011; Peng et al., 2003; Xu et al., 2009) .
Providing a potential explanation for this apparent redundancy, we propose that the combination of different chain types allows formation of branched conjugates with improved signaling capacity. Branched conjugates with multiple blocks of K11-linked chains, as generated by the APC/C, increased the efficiency of substrate recognition by the proteasome, and, accordingly, promoted degradation in purified systems, extracts, or cells even under conditions of low APC/C activity. Thus, distinct from randomly branched chains that impair degradation (Kim et al., 2007) , the branched conjugates assembled by the APC/C act as particularly powerful proteolytic signals.
Why branched chains with multiple blocks of K11-linkages facilitate proteasomal degradation requires further analysis. We favor the idea that the higher signal capacity of branched chains originates from increased levels of substrate-attached ubiquitin, which overcome the modest affinity of effectors toward ubiquitin. As longer ubiquitin chains do not provide a similar effect (Figure 5C; Thrower et al., 2000) , it is likely that ubiquitin has to be concentrated close to the substrate, thus promoting multivalent recognition by effectors with several ubiquitin-binding domains in the same complex. Indeed, the proteasome and p97, both of which efficiently bind branched chains, contain multiple binding domains for ubiquitylated substrates (Finley, 2009; Lander et al., 2012; Richly et al., 2005) . If this hypothesis were correct, we expect that multiple short chains attached to neighboring substrate lysines should also stimulate degradation. However, few substrates have clusters of Lys residues allowing the formation of such structures. Moreover, attachment of the first ubiquitin to a substrate Lys is often the rate-limiting step of chain formation (Pierce et al., 2009; Williamson et al., 2011) , and cleavage of the proximal ubiquitin represents the rate-limiting step of degradation (Finley, 2009) . The capacity of branched chains to increase the ubiquitin density without introducing more ratelimiting steps could provide an explanation for why these conjugates generate a particularly powerful proteolytic signal.
Evolutionary Implications of Branched Chain Formation
Our discovery that human APC/C assembles branched chains might provide insight into the changes in linkage specificity that occurred between yeast and metazoan APC/C. As yeast APC/C initiates chain formation with Ubc4/5, a set of E2s that add single ubiquitin molecules to substrates (Rodrigo-Brenni and Morgan, 2007) , it is unlikely to support branching. Metazoan APC/C synthesizes branched chains with Ube2C and Ube2S, two E2s that are not present in yeast. In this study, we found that Ube2S plays an important role in prometaphase, a cell-cycle stage that is different in yeast, which undergoes closed mitosis, and metazoans, where nuclear envelope breakdown dictates that spindle assembly occurs without the chromosomes being confined to a subcellular compartment. Possibly reflecting these differences, few substrates are degraded during prometaphase in yeast, whereas in metazoans several examples of APC/C substrate degradation have been reported at this cell-cycle time (Amador et al., 2007; Hayes et al., 2006; Sedgwick et al., 2013; Song and Rape, 2010; Wolthuis et al., 2008) . In addition, prometaphase APC/C continuously disassembles spindle checkpoint complexes, resulting in a dynamic interplay between the APC/C and the checkpoint. Checkpoint disassembly is strongly promoted by a metazoan-specific protein, p31 comet , which might point to an increased extent of checkpoint disassembly in these organisms (Foster and Morgan, 2012; Reddy et al., 2007; Uzunova et al., 2012; Varetti et al., 2011; Williamson et al., 2009 ). We therefore speculate that the increased proteolytic capacity of branched chains, formation of which required the emergence of Ube2C and Ube2S, allowed the metazoan APC/C to cope with higher demands on its activity during early stages of cell division.
EXPERIMENTAL PROCEDURES
An extended version can be found in the Extended Experimental Procedures.
Plasmids
Ube2G2
CTP was generated by fusing human Ube2G2 to residues 186-222 of Ube2S. To produce Ub-Ub-cyclin A, ubiquitin 1-74 was fused to Ub-cyclin A with a GSEDLYFQSG linker. To generate Ub 3 -cyclin A or Ub 3 -Nek2A 272-445 , a 3x ubiquitin DNA template was synthesized and fused to the substrate. TEV ubiquitin derivatives were created by inserting a TEV site after G53 (SENLYFQGS), E64 (NLYFQG), or L71 (GSENLYFQGS). A FLAG-epitope was added after E64 to create TEV/FLAG. Mutagenesis to create K11R, K48R, and K63R mutations was performed as described.
APC/C Ubiquitylation 35 S-labeled substrates were synthesized by in vitro transcription/translation. APC/C was purified from G1-HeLa cells, and endogenous Ube2S was washed off by 500 mM NaCl and 0.1% Triton. Beads were incubated for 30 min with E1, 60 mM ubiquitin, 3 mM ATP, 22.5 mM creatine phosphate, 1 mM DTT, and substrate. The concentrations of Ube2S, Ube2G2, and Ube2G2 CTP were 10 mM, of Ube2C in combination with Ube2S or Ube2G2 CTP 100 nM, and of Ube2C by itself 10 mM.
Branched Chain Detection
To detect branched linkages on Nek2A, 5 mM His Nek2A 272-445 was incubated with APC/C, 100 nM E1, 3 mM ATP, 22.5 mM creatine phosphate, 1 mM DTT, 10 mM Ube2C, 10 mM Ube2S, 60 mM ubi 
